Monitoring the radiation dose to a multiprogrammable pacemaker during radical radiation therapy: a case report.
Multiprogrammable pacemakers, using complimentary metaloxide semiconductor (CMOS) circuitry, may fail during radiation therapy. We report about a patient who received 6,400 cGy for unresectable carcinoma of the left lung. In supine treatment position, arms raised above the head, the pacemaker was outside the treated area by a margin of at least 1 cm, shielded by cerrobend blocking mounted on a tray. From thermoluminescent dosimeter (TLD) measurements, we estimate that the pacemaker received 620 cGy in scatter doses. Its function was monitored before, during, and after completion of radiation therapy. The pacemaker was functioning normally until the patient's death 5 months after completion of treatment. The relevant electrocardiograms (ECGs) are presented.
Muller-Runkel
R
R
Saint Margaret Hospital and Health Centers, Hammond, In 46320.
Orsolini
G
G
Kalokhe
U P
UP
D000368:Aged; D004562:Electrocardiography; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008297:Male; D010138:Pacemaker, Artificial; D011829:Radiation Dosage; D011835:Radiation Protection; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D013819:Thermoluminescent Dosimetry